Immunomedics (Immunomedics) Net Margin % : -331.10% (As of Jun. 2020)

Immunomedics Net Margin % Chart

Immunomedics Annual Data
	Trend	Jun10	Jun11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun17	Jun18	Dec19
Net Margin %		Get a 7-Day Free Trial					-849.14	-1,826.07	-4,956.52	-12,701.16	-121,081.36

Immunomedics Quarterly Data
	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20
Net Margin %	Get a 7-Day Free Trial															-	-	-33,765.42	-	-331.10

Competitive Comparison of Immunomedics's Net Margin %

For the Biotechnology subindustry, Immunomedics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunomedics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunomedics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Immunomedics's Net Margin % falls into.

Immunomedics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Immunomedics's Net Margin for the fiscal year that ended in Dec. 2019 is calculated as

Immunomedics's Net Margin for the quarter that ended in Jun. 2020 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunomedics  (NAS:IMMU) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Immunomedics Net Margin % Related Terms

Thank you for viewing the detailed overview of Immunomedics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunomedics (Immunomedics) Business Description